A monthly recap of the latest news about Alzheimer’s and dementia FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval Learn about the new Alzheimer’s drug, Lecanemab, the FDA has approved for treatment. Read more here. Donanemab in Early Symptomatic Alzheimer Disease Learn more about the details surrounding donanemab and its results in
A monthly recap of the latest news about Alzheimer’s and dementia Lilly drug slows Alzheimer's by 35%, bolstering treatment approach An experimental Alzheimer's drug developed by Eli Lilly and Co (LLY.N) slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing what experts say is the strongest evidence yet
A monthly recap of the latest news about Alzheimer’s and dementia US health officials aim to ‘transform’ Alzheimer’s disease research with $300 million data platform The US National Institute on Aging is moving forward with efforts to build a real-world Alzheimer’s disease database as part of its aim to improve, support and conduct more
As we age, we can experience changes in our physical and cognitive capabilities. However, some older adults have more memory or thinking problems than other adults at their age. This condition is called mild cognitive impairment (MCI). In Orange County over 164,000 people are living with dementia or MCI. Currently, research has not indicated one
A monthly recap of the latest news about Alzheimer’s and dementia Study of green tea and other molecules uncovers new therapeutic strategy for Alzheimer’s Researchers have discovered how a molecule found in green tea breaks apart tangles of the protein tau, a hallmark of Alzheimer’s disease. Read more here. Estimates of amyloid
A monthly recap of the latest news about Alzheimer’s and dementia Microphysiological systems: A promising new platform for Alzheimer’s drug development One of the biggest and most persistent challenges in the quest for effective Alzheimer’s disease and related dementias therapies is finding better models for preclinical drug development. Read more here. FDA Grants
A monthly recap of the latest news about Alzheimer’s and dementia New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows A team led by researchers at the University of Washington has developed a laboratory test that can measure levels of amyloid beta oligomers in blood samples. Read more here.
A monthly recap of the latest news about Alzheimer’s and dementia Study: Alzheimer's drug shows modest success slowing declines in memory, thinking The drug, called lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800 people in the early stages of Alzheimer's. Read more here. Vision impairment is
A monthly recap of the latest news about Alzheimer’s and dementia Exposure to environmental toxins may be root of rise in neurological disorders Doctors warn exposure to omnipresent yet poorly understood chemicals such as microplastics could play a role in dementia. Read more here. After promising data, experts say many questions remain over
A monthly recap of the latest news about Alzheimer’s and dementia Walk this number of steps each day to cut your risk of dementia Need another reason to walk? How much you walk may reduce your risk of mental decline, according to a new study. Read more here. Could Ultrasound Help Detect Alzheimer’s
